课题基金 / 基金详情

Modulation of cardiac potassium channels in pathological conditions and developments

Modulation of cardiac potassium channels in pathological conditions and developments
心脏钾通道在病理状况和发展中的调节
批准号:
09670710
负责人:
KAMIYA Kaichiro
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

KAMIYA Kaichiro的其他基金

相似基金

相关文献

中文摘要
翻译
在这项研究中。我们研究了在不同类型的病理条件和发育变化过程中心脏钾通道的调节。并探讨了基因调控通道的可能作用。K通道mRNA的水平。观察培养心肌细胞和肥厚心肌细胞中通道蛋白、空间分布通道蛋白及离子电流水平。本研究主要发现:1)甲状腺激素对各心脏通道的影响不同。2)单致右心室肥厚时动作电位持续时间的延长最初是由钙电流升高引起的,后来是由瞬时外电流降低引起的。3)对心肌通道的影响与心肌肥厚的类型有关。不同的调制取决于。以上研究结果均已接受在后面列出的期刊上发表。本研究中使用的分子方法都是近十年来发展起来的。这些在方法学上的显著进步可能会导致对患病心脏通道行为的进一步理解。
英文摘要
In this study. we examined the modulation of cardiac potassium channels in various types of pathological conditions and during developmental changes. Possible role of gene regulation of channels was also examined. Levels of K channel mRNA.levels of channel protein, spatial distribution channel protein and ion currents were observed in cultured cardiac myocytes or hypertrophied hearts. Main findings obtained during this grant were :1) Thyroid hormone exhibit diffeerent effects on each cardiac channels.2) The prolongation of action potential duration in monocrotalin-induced right ventricular hypertrophy was caused initially by increase in calcium current and lately by decrease in transient outward current.3) Effects on cardiac channels were dependent on the types of cardiac hypertrophy. differently modulated depends.All of above findings have already accepted to publish in journals listed later.The molecular methods used in this study were all developed in these ten years. These remarkable progresses in methodology may lead to further understanding of channel behavior in diseased hearts.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
GUO Weinong, KAMIYA Kaichiro, YASUI Kenji, KODAMA Itsuo, TOYAMA Junji: "alpha_1-Adrenoceptor agonists and IGF-1, myocardial hypertrophic factors, regulate the Kv1.5 K^- channel expression differentially in cultured newborn rat ventricular cells." Pflugers
GUO Weinong、KAMIYA Kaichiro、YASUI Kenji、KODAMA Ituo、TOYAMA Junji:“α_1-肾上腺素受体激动剂和 IGF-1、心肌肥大因子,在培养的新生大鼠心室细胞中差异调节 Kv1.5 K^- 通道表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
HISHIYAMA A., KAMBE F., KAMIYA K., et al.: "Effects of thyroid status on expression of voltage-gated potassium channels." Cardiovascular Research. 40. 343-351 (1998)
HISHIYAMA A.、KAMBE F.、KAMIYA K. 等人:“甲状腺状态对电压门控钾通道表达的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
NISHIYAMA Atsushi,KAMBE Fukushi,KAMIYA Kaichiro,SEO Hisao,TOYAMA Junji:"Effects of thyroid hormone on the expression of Kv4.2 and Kv 4.3 potassium channel genes in the rat heart." Environmental Medicine. 41.2. 117-119 (1997)
NISHIYAMA Atsushi、KAMBE Fukushi、KAMIYA Kaichiro、SEO Hisao、TOYAMA Junji:“甲状腺激素对大鼠心脏 Kv4.2 和 Kv 4.3 钾通道基因表达的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
神谷香一郎,外山淳治: "不整脈の電気生理学的機序." 「抗不整脈薬のすべて」Part2基礎編. 49-93 (1997)
Koichiro Kamiya,Junji Toyama:“心律失常的电生理机制”。“关于抗心律失常药物”第 2 部分基础版(1997 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 36 条
    Molecular mechanism and clinical trial center for the drug-induced QT prolongation syndrome
    • 批准号:
      16390222
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2004
    • 负责人:
      KAMIYA Kaichiro
    • 依托单位:
    Molecular mechanisms and its prevention of drug-induced long QT syndrome
    • 批准号:
      14370222
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.83万
    • 财政年份:
      2002
    • 负责人:
      KAMIYA Kaichiro
    • 依托单位:
    Polymorphism of cardiac K^+ channel gene and hyperactivity of drugs
    • 批准号:
      12670656
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2000
    • 负责人:
      KAMIYA Kaichiro
    • 依托单位:
    Drug design for cardiac treatment by control of K channel
    • 批准号:
      10044259
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.26万
    • 财政年份:
      1998
    • 负责人:
      KAMIYA Kaichiro
    • 依托单位:
    海外基金